Drug Type Chemical drugs |
Synonyms AUTO 01, AUTO01, NN/AUTO-01 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 06 Dec 2023 | |
| Ankylosing Spondylitis | Preclinical | United States | 06 Dec 2023 | |
| Cardiovascular Diseases | Preclinical | United States | 06 Dec 2023 | |
| Depressive Disorder | Preclinical | United States | 06 Dec 2023 | |
| Diabetes Mellitus, Type 2 | Preclinical | United States | 06 Dec 2023 | |
| MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | United States | 06 Dec 2023 | |
| Psoriasis | Preclinical | United States | 06 Dec 2023 | |
| Sepsis | Preclinical | United States | 06 Dec 2023 | |
| Sjogren's Syndrome | Preclinical | United States | 06 Dec 2023 | |
| Stress Disorders, Post-Traumatic | Preclinical | United States | 06 Dec 2023 |





